What is the HBsag test

Diagnosis

Diagnostics for hepatitis B should be offered widely. A hepatitis B search diagnosis should always be carried out at

  • Patients with elevated liver values ​​or clinical signs of hepatitis
  • Cirrhotic patients
  • Patients with hepatocellular carcinoma
  • Persons with a migration background from countries with an increased HBs-Ag prevalence, family members and household contacts as well as sexual partners of HBs-Ag positive patients
  • Patients before or during an immunosuppressive therapy (reactivation under chemotherapy possible)
  • Medical staff
  • Patients in psychiatric institutions
  • Homosexual men and patients with frequently changing sexual partners
  • When diagnosing other sexually transmitted diseases (syphilis, HIV, hepatitis C).

Antibody course

The diagnosis of chronic hepatitis B can be made by an HBs-Ag search test. If this is positive, a complete hepatitis serology should be taken (anti-Hbs-AK, HBe-Ag, HBe-AK, anti-HBc-AK) and the hepatitis B viraemia (HBV-DNA) should be determined. In addition, tests should be carried out for hepatitis A, C and D and for HIV. Further laboratory tests are the transaminases, the liver synthesis parameters (albumin, Quick, cholinesterase), the blood count and the AFP as tumor markers.

Hepatitis B screening: step-by-step diagnosis

  • HBs antigen: search marker for hepatitis B infection
  • HBc antibodies: search marker for hepatitis B infection
  • HBs antibodies: only with positive HBsAg and / or HBc-Ab
  • HBc-IgM antibodies: only after a pathological search test
  • HBe antigen: only after pathological screening test
  • HBe antibodies: only after a pathological search test

Source: www.laborbauer.at

Messages

  • Fight hepatitis C together

    April 29, 2021: PLUS initiative

  • Hepatitis C.

    April 28, 2021: STI as a predictor of reinfection

  • COVID-19 and Public Health

    April 28, 2021: How did the public health service react to Corona in Germany?

  • Scholarship German Liver Foundation

    April 27, 2021: Application for an exemption scholarship for 2022 Hepatology is now possible.

  • Corona vaccination

    April 22, 2021: J & J's vector vaccine also effective against variants

  • HIV funding program

    April 20, 2021: You can apply for the Gilead HIV funding program until June 15, 2021.

  • Health Department Day

    March 19, 2021: The motto for the occasion "Crisis Response"

  • Corona vaccination

    March 14, 2021: EU approval for Janssen's single-use vaccine

  • Hepatitis D

    February 22, 2021: Non-quantifiable additional benefit for Hepcludex®

  • Hepatitis E.

    February 17, 2021: Viruses survive in the ejaculate of chronically infected patients

  • Hepatitis C.

    February 11, 2021: Need for clarification and action

  • Addendum DGVS guidelines HCV

    December 10, 2020: DGVS guideline recommends immediate start of therapy for chronic HCV infection.

  • Check-up 35

    November 22, 2020: Screening for hepatitis B and C is a new part of the health check-up

  • Hepatitis C.

    November 22, 2020: Addendum to the S3 guideline published

  • Flu shot

    November 15, 2020: Fluzone® High Dose Quadrivalent vaccine for people over 65 on the market

  • Test, advise, treat!

    October 20, 2020: Those interested can find out the most important things about hepatitis C in a new educational video

  • Hepatitis C.

    September 28, 2020: EASL guideline on rare genotypes

  • COVID-19

    September 25, 2020: ENSEMBLE vaccine study started

  • Hepatitis C.

    September 21, 2020: New EASL guideline recommends therapy for everyone.

  • PrEP

    September 21, 2020: HIV infection under PrEP

Older messages

This website provides information on all aspects of liver disease. The focus is on the viral hepatitis hepatitis A, hepatitis B, hepatitis C, hepatitis D and hepatitis E, fatty liver and liver cancer. The clinical picture, diagnosis and therapy are treated. Much has changed in the treatment of hepatitis B and hepatitis C in particular. Here you will find an overview of the drugs available against hepatitis B and C, study data, specialist information and current prices. The current information from medicine and industry is aimed at those affected and doctors.